Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on the USMCA Biotech Corn Dispute…
Today the dispute settlement panel formed under the United States-Mexico-Canada Agreement (USMCA) issued a final ruling related to Mexico's restrictions on the importation of genetically modified (GM) corn. In response, John Crowley, President…
Learn more
BIO Applauds the Inclusion of Important Health…
John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), today released the following statement ahead of an expected vote in the U.S. House of Representatives on a year-end government funding bill that includes many…
Learn more
BIO Appoints Veteran Communications Leader Sarah…
Today, the Biotechnology Innovation Organization (BIO) named Sarah Alspach as its new executive vice president and chief communications officer. Alspach, a communications veteran, will join BIO’s senior leadership team. Her first day will be…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Releases Statement Concerning Future Political Giving
January 11, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on BIO's political contributions:   "As of today BIO will be pausing our political giving so we can…
BIO Statement on CMS' Approval of TennCare Medicaid Waiver
January 11, 2021
Dan Durham, Executive Vice President for Health Policy at the Biotechnology Innovation Organization, released the following statement regarding the recent decision by the Centers for Medicare and Medicaid Services (CMS) to approve the Tennessee…
BIO's Dr. Michelle McMurry-Heath Responds to "Unconscionable" Attacks on U.S. Capitol
January 6, 2021
Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization, made the following comments in response to today's violence at the United States Capitol: "Today we watched in horror as angry and unruly mobs attacked…
Injunction Placed on Punitive and Political Maneuver by Administration
December 29, 2020
A judge in the United States District Court for the Northern District of California yesterday issued a preliminary injunction blocking the Administration’s “Most Favored Nation” reimbursement policy for certain drugs administered by Medicare Part B…
Modernizing Oversight of Animal Biotechnology Will Help Tackle Climate Change and Nutrition Challenges
December 21, 2020
The Biotechnology Innovation Organization (BIO) appreciates the U.S. Department of Agriculture’s (USDA) longstanding commitment to food and agricultural innovation and looks forward to reviewing the Advanced Notice of Proposed Rulemaking (ANPR)…
New Website Will Combat Vaccine Myths, Boost Public Confidence, Increase Acceptance
December 4, 2020
Public opinion polls show there is significant mistrust among the American public in the safety and efficacy of vaccines. So today, the Biotechnology Innovation Organization (BIO) announced the launch of COVIDVaccineFacts.org. As a subsidiary…
BIO Leads Group Challenging Administration’s “Most Favored Nation” Rule
December 4, 2020
The Biotechnology Innovation Organization (BIO), the California Life Sciences Association (CLSA), and BIOCOM California today filed a challenge against the Department of Health and Human Services’ (HHS) attempt, during the final days of the Trump…
BIO's Dr. McMurry-Heath Applauds Nasdaq's Proposal on Mandatory Diversity for Listed Companies
December 2, 2020
Washington, DC (December 2, 2020) - Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement regarding Nasdaq's filing with the Securities and Exchange Commission…
BIO’s Dr. McMurry-Heath Calls Foreign Price Controls a “Fatally Flawed Regulation” That Will “Endanger Our Most Vulnerable Americans”
November 20, 2020
Washington, DC (November 20, 2020) – Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose…
BIO’s Dr. Michelle McMurry-Heath Congratulates President-Elect Biden & Other Newly Elected Leaders of Both Parties Who Won
November 7, 2020
"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today